| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/09/2008 | US20080248495 Protease Activated Receptor (PAR) activating peptide for use as screening tool in identifying modulators for treatment of thrombosis |
| 10/09/2008 | US20080248044 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination |
| 10/09/2008 | US20080248008 Transferase inhibitory mimetic for use in treatment and prevention of immunosuppressive, cell proliferative and autoimmune disorders |
| 10/09/2008 | US20080247999 Cyclin dependent kinase-4 (CDK-4) peptides for use in treatment of cell proliferative disorders; antitumor agents |
| 10/09/2008 | US20080247988 Methods of making and using surfactant polymers |
| 10/09/2008 | US20080247950 Proteases of human kallikrein 2 (hK2); tissue imaging |
| 10/09/2008 | CA2682575A1 Diagnostic assay |
| 10/09/2008 | CA2682174A1 Stitched polypeptides |
| 10/09/2008 | CA2681935A1 Treatment of obesity |
| 10/08/2008 | EP1978095A1 Chimeric receptor proteins for controlling signal transduction and ligands binding thereto |
| 10/08/2008 | EP1978026A1 Novel t-helper antigenic determinant (thd) peptides |
| 10/08/2008 | EP1978025A1 Novel kappa receptor selective opioid peptides |
| 10/08/2008 | EP1976862A2 Novel peptides and the biological use thereof |
| 10/08/2008 | EP1976861A2 Inhibiting tumour cell invasion, metastasis and angiogenesis through targetting legumain |
| 10/08/2008 | EP1809654B1 Heterocyclyl-substituted nonadepsipeptides |
| 10/08/2008 | EP1572727B1 On-growth inhibiting compounds |
| 10/08/2008 | EP1507795B1 Tumour-associated peptides that bond to mhc molecules |
| 10/08/2008 | EP1466179B1 Method for the diagnosis of cancers by measuring the changes of glycosylation of prostate-derived factor (pdf) related to tumorigenesis and metastasis. |
| 10/08/2008 | CN101282991A N-terminally modified GLP-1 receptor modulators |
| 10/08/2008 | CN101282705A Method for enhancing effects of colorants and conditioners |
| 10/08/2008 | CN101280005A Preparation of PT141 |
| 10/08/2008 | CN101280004A Polypeptide ERC(N5) for specific inhibition of tumor cell and tumor angiogenic blood vessel |
| 10/08/2008 | CN101280003A Protein-stable bioactivity-protected polypeptides, coding genes, recombinant expression vectors, expressing escherichia coli strain and application thereof |
| 10/08/2008 | CN100424509C Method of detecting autoantibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit |
| 10/08/2008 | CN100424096C Survivin mutant containing HIV transduction structural area and its preparation method and uses |
| 10/08/2008 | CN100424093C Peptides which can bind to transforming growth factor beta 1 (tgf-beta1) |
| 10/07/2008 | US7432343 MAIL: Molecule possessing Ankyrin repeats Induced by Lipopolysaccharide or I theta B-zeta; antigenic peptide; detection and treatment of carcinomas, especially metastatic breast cancer |
| 10/07/2008 | US7432342 Kinase anchor protein muteins, peptides thereof and related documents |
| 10/07/2008 | US7432341 A decapeptide: EATVGERVRL, which is a non-competitive extracellular cytokine receptor antagonist; decreases vascular endothelial growth factor-induced neovascularization; treating inflammatory, autoimmune and vascular diseases. |
| 10/07/2008 | US7432245 Pharmaceutical formulation comprising a peptide angiogenesis inhibitor |
| 10/07/2008 | US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas |
| 10/07/2008 | US7432061 Assays for measuring matrix metalloproteinase activities |
| 10/07/2008 | US7432045 Membrane transiting peptides having antiviral properties; respiratory disorders |
| 10/07/2008 | US7431934 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 10/07/2008 | US7431915 Peptides whose uptake by cells is controllable |
| 10/07/2008 | CA2388910C Antimicrobial activity of the first cationic cluster of human lactoferrin |
| 10/07/2008 | CA2329738C Method of predicting the ability of compounds to modulate the biological activity of receptors |
| 10/07/2008 | CA2223449C Peptides and compounds that bind to the thrombopoietin receptor |
| 10/07/2008 | CA2209426C Human pak65 |
| 10/07/2008 | CA2087494C Soluble ldl receptor, its production and use |
| 10/05/2008 | CA2583999A1 Characterization of a mekk binding site and uses thereof |
| 10/02/2008 | WO2008117833A1 Process for synthesizing cyclic peptide compound |
| 10/02/2008 | WO2008050161A3 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds |
| 10/02/2008 | WO2008035093A3 Peptides |
| 10/02/2008 | WO2007146228A3 Elastin-based copolymers |
| 10/02/2008 | WO2007127135A3 Antibiotic compounds |
| 10/02/2008 | WO2007089601A8 Nogo receptor antagonists |
| 10/02/2008 | US20080242838 Multifunctional labels in proteomics; lysine specific and increase overall sequence coverage obtained in polypeptide mapping by increasing ionization efficiencies |
| 10/02/2008 | US20080242837 Peptide compositions |
| 10/02/2008 | US20080242836 Deblocking, deprotecting; HPLC |
| 10/02/2008 | US20080242619 Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders |
| 10/02/2008 | US20080242617 Two component bacillus lantibiotic and methods for producing and using the same |
| 10/02/2008 | US20080242616 Peptide specificity of anti-myelin basis protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 10/02/2008 | US20080242614 Polypeptide containing valine or proline; therapy for infections |
| 10/02/2008 | US20080242598 Short chain peptide; conformation scaffolds; diecting amino acids into positions; controlling apoptosis; tumor suppression; alcoholism; drug abuse; antiepileptic agents |
| 10/02/2008 | US20080242593 Such as 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(6-(2-ethylphenyl)pyridin-3-yl)propanoic acid; stability to proteolytic cleavage |
| 10/02/2008 | US20080241945 Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions |
| 10/02/2008 | US20080241859 Using aglycoprotein 10B antibody as diagnostic tool in detection of cell proliferative disorders associated with chronic viral diseases |
| 10/02/2008 | US20080241194 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 10/02/2008 | US20080241156 Inhibitors of hepatitis C virus |
| 10/02/2008 | US20080241108 Bone Morphogenic Protein Binding Peptide |
| 10/02/2008 | CA2682021A1 Peptides with the capacity to bind to interleukin-10 (il-10) |
| 10/02/2008 | CA2680837A1 Mek ligands and polynucleotides encoding mek ligands |
| 10/01/2008 | EP1975179A1 Polyclonal antibodies, preparation method thereof and use of same |
| 10/01/2008 | EP1317274B1 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 10/01/2008 | CN101278051A Personal care compositions and methods for their use |
| 10/01/2008 | CN101274958A Bioactive peptide, preparation thereof and application thereof |
| 10/01/2008 | CN101274957A Human cytomegalovirus M epitope and application thereof to medical research field |
| 10/01/2008 | CN100422209C Sea snail toxin variant polypeptide compound, its preparation process and application thereof |
| 09/30/2008 | US7429559 Controlled release composition and method of producing the same |
| 09/30/2008 | US7429379 TNF receptor action modulation |
| 09/25/2008 | WO2008116171A1 Cyclic receptor-associated protein (rap) peptides |
| 09/25/2008 | WO2008114976A1 Spinorphin derivatives as potent and selective human p2x3 receptor antagonist |
| 09/25/2008 | WO2008114037A1 Treatment of inflammation and/or endotoxic shock |
| 09/25/2008 | WO2008113834A2 C5 antigens and uses thereof |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234464 Compound Having Amino Acid Residue or Peptide Residue and Process for Producing the Same |
| 09/25/2008 | US20080234205 Antineoplastic peptides |
| 09/25/2008 | US20080234201 BH3 peptides and method of use thereof |
| 09/25/2008 | US20080234192 Compositions and methods of use for treating cardiovascular disease |
| 09/25/2008 | US20080234188 Antimicrobial Peptides |
| 09/25/2008 | US20080234183 Predicting or designing, detecting, and/or verifying a novel cell-penetrating peptide that mimics cellular effector activity; vectors; treating and/or preventing infectious diseases, diabetes type I and II, Alzheimer's Disease, Parkinson's Disease, and cancer. |
| 09/25/2008 | US20080234132 Inhibitors of DNA gyrase; for inhibiting bacterial infections, treating cancer, controlling plant growth and seed germination |
| 09/25/2008 | US20080233137 Block the inflammatory and immunomodulatory activity mediated by endogenous C5a; Adult Respiratory Distress Syndrome (ARDS), severe tissue damage following thrombotic events such as heart attacks and stroke, inflammatory bowel diseases and rheumatoid arthritis |
| 09/25/2008 | US20080233136 Biologically Active Peptides |
| 09/25/2008 | US20080233081 Pro-angiogenic peptides |
| 09/25/2008 | US20080233050 Using cyanine dyes; in situ supplying to tumor cells |
| 09/25/2008 | US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy |
| 09/25/2008 | CA2684382A1 Treatment of inflammation and/or endotoxic shock |
| 09/25/2008 | CA2681522A1 Cyclic receptor-associated protein (rap) peptides |
| 09/25/2008 | CA2680760A1 C5 antigens and uses thereof |
| 09/25/2008 | CA2680708A1 Metal-binding therapeutic peptides |
| 09/24/2008 | EP1972939A1 Method for the diagnosis of cancers by measuring the changes of glycosylation of TIMP-1 related to tumorigenesis and metastasis, and kit for diagnosis of cancers using the same |
| 09/24/2008 | EP1560558A4 Use of 3-position cyclosporin derivatives for hair growth |
| 09/24/2008 | EP1084239B1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1) |
| 09/24/2008 | CN101270154A Cyclo-pentapeptide with antineoplastic activity |
| 09/24/2008 | CN101270153A Cyclo-pentapeptide and synthesizing method |
| 09/24/2008 | CN101270152A Peptide medicament series for accelerating medulla hematopoiesis cell proliferation |
| 09/24/2008 | CN101270151A Peptide medicaments for accelerating medulla hematopoiesis cell proliferation |
| 09/24/2008 | CN101270150A Truncate soluble human vascellum endothelial cell growth factor acceptor, prepraring method and uses thereof |